VITTA Radiotherapy Center, Brasília-DF, Brazil.
Department of Radiation Oncology, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, United States.
J Appl Clin Med Phys. 2022 Dec;23(12):e13822. doi: 10.1002/acm2.13822. Epub 2022 Nov 10.
The aim of this work was to evaluate the SunCHECK PerFRACTION, the software for in vivo monitoring using EPID images.
MATERIALS/METHODS: First, the PerFRACTION ability to detect errors was investigated simulating two situations: (1) variation of LINAC output and (2) variation of the phantom thickness. An ionization chamber was used as reference to measure the introduced dose variations. Both tests used EPID in integrated mode (absolute dose). Second, EPID measurements in integrated mode were carried out during an independent Brazilian governmental audit that provided four phantoms and TLDs. PerFRACTION calculated the absolute dose on EPID plane, and it compared with predicted calculated dose for every delivered plan. The dose deviations reported using PerFRACTION were compared with dose deviations reported by the independent audit. Third, an end-to-end test using a heterogeneous phantom was performed. A VMAT plan with EPID in cine mode was delivered. PerFRACTION calculated the mean dose on CBCT using EPID information and log files. The calculated doses at four different points were compared with ionization chambers measurements.
About the first test, the largest difference found was 1.2%. Considering the audit results, the variations detected by TLD measurements and by PerFRACTION dose calculation on EPID plane were close: 12 points had variations less than 2%, 2 points with variation between 2% and 3%, and 2 points with deviations greater than 3% (max 3.7%). The end-to-end tests using a heterogeneous phantom achieved dose deviation less than 1.0% in the water-equivalent region. In the mimicking lung region, the deviations were higher (max 7.3%), but in accordance with what is expected for complex situations.
The tests results indicate that PerFRACTION dose calculations in different situations have good agreement with standard measurements. Action levels were suggested for absolute dose on EPID plane as well as 3D dose calculation on CBCT using PerFRACTION.
本研究旨在评估 SunCHECK PerFRACTION 软件,该软件可用于使用 EPID 图像进行体内监测。
材料/方法:首先,我们模拟了两种情况来评估 PerFRACTION 检测误差的能力:(1) LINAC 输出的变化和(2)体模厚度的变化。使用电离室作为参考来测量引入的剂量变化。这两个测试均使用 EPID 集成模式(绝对剂量)。其次,在巴西政府独立审计期间进行了 EPID 集成模式的测量,该审计提供了四个体模和 TLD。PerFRACTION 在 EPID 平面上计算绝对剂量,并将其与每个计划的预测计算剂量进行比较。使用 PerFRACTION 报告的剂量偏差与独立审计报告的剂量偏差进行了比较。最后,我们进行了一个使用不均匀体模的端到端测试。使用 EPID 电影模式交付了一个 VMAT 计划。PerFRACTION 使用 EPID 信息和日志文件计算 CBCT 上的平均剂量。在四个不同点计算的剂量与电离室测量值进行了比较。
关于第一个测试,发现的最大差异为 1.2%。考虑到审计结果,TLD 测量和 PerFRACTION 在 EPID 平面上的剂量计算检测到的变化非常接近:12 个点的变化小于 2%,2 个点的变化在 2%至 3%之间,2 个点的变化大于 3%(最大 3.7%)。使用不均匀体模进行的端到端测试在水等效区域实现了小于 1.0%的剂量偏差。在模拟肺区域,偏差较高(最大 7.3%),但符合复杂情况下的预期。
这些测试结果表明,PerFRACTION 在不同情况下的剂量计算与标准测量具有良好的一致性。还为 EPID 平面上的绝对剂量以及使用 PerFRACTION 在 CBCT 上的 3D 剂量计算建议了行动水平。